• SLT results in a biological response that increases aqueous drainage, and reduces IOP.
  
  
• No adverse reactions from medications.
  
  
• No adverse scarring of trabecular meshwork.
  
  
• May reduce the need for lifelong use of expensive eyedrops and other medications.
  
  
• May reduce or eliminate the trouble of always having to take glaucoma medications.
  

How is SLT Performed?

SLT is usually performed in the office and only takes about 15-20 minutes. Prior to the procedure, eyedrops will be given for anesthesia and to prepare the eye for treatment. The laser applications are made through a slit-lamp microscope, similar to the one used for eye examinations. About one hour of office time should be planned so the IOP can be checked after the eye is treated.


What Should Be Expected After SLT Treatment and What Are the Risks?

The IOP should drop within several weeks of having the SLT performed. The doctor may treat the eye with anti-inflammatory eyedrops that will be continued for 4-7 days after the procedure. Most patients will have to return for follow-up visits to recheck the treated eye. Although highly effective, SLT does not always lower the intraocular pressure. If there is little or no response, the treatment may be repeated. If there is still no improvement, further treatments are unlikely to be of benefit.

Unlike some glaucoma medications, there are no incidences of allergy or systemic side effects with SLT. Complications are minimal but may include inflammation, transitory IOP spike, conjunctivitis, or eye pain. The chance of worsening or loss of vision is remote. For more information about SLT and its benefits and possible adverse effects please ask your doctor at Heaton Eye Associates.

You can also visit this website to learn more about SLT, the new treatment that is used for Glaucoma patients. http://www.ophthalmic.lumenis.com/wt/content/slt


Prevention is the Best Medicine

Vision loss from glaucoma is permanent but can usually be prevented with early detection and treatment. Glaucoma management csn be a life-long process requiring frequent monitoring and constant treatment. Since there is no way to determine if glaucoma is under control based on how a person feels or their vision, a person with glaucoma generally should be examined every 3-6 months for the rest of their lives.